Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Blackfinch Spr. Share Price
  4. Blackfinch Spr. Share Regulatory News
  5. Annual Financial Report

Pin to quick picksBlackfinch Spr. Regulatory News (BFSP)

Blackfinch Spr. Information

Share Price Information for Blackfinch Spr. (BFSP)

Share Price is delayed by 15 minutes
Get Live Data
85.00    0.00 (0.00%)
Bid:
83.00
Ask:
87.00
Spread: 4.00 (4.819%)
Market Cap: £74.46m
BFSP Live PriceLast checked at - London Stock Exchange

Intraday Blackfinch Spr. Share Chart

Annual Financial Report

21 Apr 2026 07:00

RNS Number : 2068B
Blackfinch Spring VCT PLC
20 April 2026
 

Blackfinch Spring VCT plc (the "Company")

LEI: 254900F3ZHVS78UV6D89

Annual Report for the Year Ended 31 December 2025 

The Directors are pleased to announce the Company's Annual Report and Financial Statements for the year ended 31 December 2025 ("Annual Report").

The Annual Report will be distributed to shareholders shortly and is available in electronic format for download on the Blackfinch website https://blackfinch.ventures/vct and will be submitted to the National Storage Mechanism https://data.fca.org.uk/#/nsm/nationalstoragemechanism. 

 Click on the following link, or paste it into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/2068B_1-2026-4-20.pdf

20 April 2026

 

For further information please contact:

Alice Bollen

Blackfinch Investments Limited

enquiries@blackfinch.com

 

Robin Smeaton

The City Partnership (UK) Limited

enquiries@city.uk.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSSELFASEMSEDL
123
Date   Source Headline
4th Jun 20263:51 pmRNSResults of AGM, 4 June 2026
21st May 20265:36 pmRNSDividend Declaration
18th May 20261:05 pmRNSIssue of Equity
7th May 20267:00 amRNSIssue of a Supplementary Prospectus
6th May 20269:46 amRNSTotal Voting Rights
28th Apr 20269:50 amRNSNet Asset Value per Share
21st Apr 20267:00 amRNSAnnual Financial Report
14th Apr 202612:59 pmRNSAdmission of Further Securities to Trading
31st Mar 20269:45 amRNSUtilisation of Over-allotment Facility
26th Mar 20261:48 pmRNSIssue of Equity
27th Feb 20267:00 amRNSIssue of Equity
2nd Feb 20265:17 pmRNSNet Asset Value per Ordinary Share
30th Jan 20264:59 pmRNSAdmission of Further Securities to Trading
28th Jan 20263:58 pmRNSIssue of Equity
27th Jan 20263:44 pmRNSChange of Registered Office Address
26th Jan 20262:23 pmRNSDeclaration of Interim Dividend
17th Dec 20256:26 pmRNSIssue of Equity
17th Dec 20256:22 pmRNSPurchase of Own Shares
20th Nov 20254:30 pmRNSIssue of Equity
19th Nov 20256:28 pmRNSIssue of Equity
10th Nov 20257:00 amRNSNet Asset Value per Share
19th Sep 20256:12 pmRNSPurchase of Own Shares
11th Sep 202511:49 amRNSPublication of Prospectus
26th Aug 20257:00 amRNSIssue of Equity
19th Aug 20254:26 pmRNSHalf-year Report
8th Aug 20255:01 pmRNSIssue of Equity
1st Aug 20259:07 amRNSNet Asset Value per Share
25th Jun 202512:37 pmRNSIssue of Equity
5th Jun 20256:12 pmRNSResult of AGM
2nd Jun 20253:55 pmRNSPurchase of own Securities
23rd May 202511:10 amRNSDeclaration of Interim Dividend
9th May 20254:25 pmRNSIssue of Equity
8th May 20251:39 pmRNSIssue of a Supplementary.Prospectus
6th May 20255:22 pmRNSNet Asset Value per Share
25th Apr 20256:28 pmRNSAnnual Financial Report
4th Apr 20253:06 pmRNSIssue of Equity
2nd Apr 20255:13 pmRNSIssue of Equity
31st Mar 202512:38 pmRNSUtilisation of Over-allotment Facility
26th Mar 20254:25 pmRNSIssue of Equity
27th Feb 20251:34 pmRNSIssue of Equity
11th Feb 20253:56 pmRNSNet Asset Value(s)
29th Jan 20255:52 pmRNSIssue of Equity
20th Jan 20255:21 pmRNSDividend Declaration
2nd Jan 20253:58 pmRNSTotal Voting Rights
13th Dec 20243:35 pmRNSIssue of Equity
4th Dec 20249:58 amRNSTotal Voting Rights
15th Nov 20245:11 pmRNSIssue of Equity
30th Oct 202411:59 amRNSIssue of Equity
28th Oct 202412:09 pmRNSNet Asset Value per Share as at 30 September 2024
10th Oct 20242:33 pmRNSResults of a General Meeting
123

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
MARS
Marstons
LSE
0.83%
AVCT
Avacta Group
LSE
-1.37%
GSK
Glaxosmithkline
LSE
-0.05%
CSRT
CSRT.L
LSE
0.00%
FRAS
Frasers Group
LSE
0.21%
Trending
EZJ
easyJet
LSE
2.78%
MAC
Marechale Cap.
LSE
-16.18%
QHE
Quantum Helium
LSE
-6.25%
KEFI
Kefi Gold & Copper
LSE
-3.49%
AVCT
Avacta Group
LSE
-1.37%